CD4 and coinfection: However, stratified analysis revealed that co-infection was significantly associated with lower resistance in patients with a treatment duration of 6-12 months (OR = 0.24, <i>P</i> = 0.001) and those with CD4 + Count ≤ 350 cells/μL (OR = 0.38, <i>P</i> = 0.001).